中华流行病学杂志
中華流行病學雜誌
중화류행병학잡지
CHINESE JOURNAL OF EPIDEMIOLOGY
2010年
7期
776-780
,共5页
杨晓莉%鲍作义%刘永健%耿海山%郝钦芳%王莉%凌爱琴%王海燕%李敬云
楊曉莉%鮑作義%劉永健%耿海山%郝欽芳%王莉%凌愛琴%王海燕%李敬雲
양효리%포작의%류영건%경해산%학흠방%왕리%릉애금%왕해연%리경운
HIV抗体检测%效率%高危人群%一般人群
HIV抗體檢測%效率%高危人群%一般人群
HIV항체검측%효솔%고위인군%일반인군
HIV antibody test%Efficiency%High risk population%General population
目的 评价中国HIV抗体检测策略在不同人群应用的效果和收益.方法 (1)收集103 133份一般人群(临床就诊病例、献血员、新兵)标本、1276份HIV感染高危人群(吸毒人群、HIV感染者的配偶)标本、2323份生化和免疫指标异常的标本,用现行HIV抗体检测策略进行检测.(2)对2002-2008年武警总医院90 289人次临床病例HIV抗体检测数据进行回顾性分析;对3个省级确认中心实验室过去3~5年确认检测的结果进行回顾性分析.结果 (1)筛查试验的收益在高危人群与一般人群显著不同,高危人群筛查阳性者中HIV抗体真阳性的比例约为50%,显著高于一般人群;主要针对一般人群的确认实验室筛查阳性标本中真阳性的比例为19.58%,显著低于主要针对高危人群的确认实验室.(2)2002-2008年临床HIV抗体检测,首次筛查阳性的真阳性率由3.7%上升到16.0%,同时,复检效率由92.6%下降为61.5%.(3)常见的生化和免疫异常未增加HIV抗体检测的非特异反应.结论 HIV抗体筛查阳性预示HIV感染的意义在不同人群有显著差别,高危人群显著高于一般人群.随着近年来HIV抗体检测试剂质量的改进和实验室质量控制水平的提高,HIV抗体首次筛查的准确性大幅度提高,而复检的效率显著下降.应考虑对不同人群采取不同的检测程序.
目的 評價中國HIV抗體檢測策略在不同人群應用的效果和收益.方法 (1)收集103 133份一般人群(臨床就診病例、獻血員、新兵)標本、1276份HIV感染高危人群(吸毒人群、HIV感染者的配偶)標本、2323份生化和免疫指標異常的標本,用現行HIV抗體檢測策略進行檢測.(2)對2002-2008年武警總醫院90 289人次臨床病例HIV抗體檢測數據進行迴顧性分析;對3箇省級確認中心實驗室過去3~5年確認檢測的結果進行迴顧性分析.結果 (1)篩查試驗的收益在高危人群與一般人群顯著不同,高危人群篩查暘性者中HIV抗體真暘性的比例約為50%,顯著高于一般人群;主要針對一般人群的確認實驗室篩查暘性標本中真暘性的比例為19.58%,顯著低于主要針對高危人群的確認實驗室.(2)2002-2008年臨床HIV抗體檢測,首次篩查暘性的真暘性率由3.7%上升到16.0%,同時,複檢效率由92.6%下降為61.5%.(3)常見的生化和免疫異常未增加HIV抗體檢測的非特異反應.結論 HIV抗體篩查暘性預示HIV感染的意義在不同人群有顯著差彆,高危人群顯著高于一般人群.隨著近年來HIV抗體檢測試劑質量的改進和實驗室質量控製水平的提高,HIV抗體首次篩查的準確性大幅度提高,而複檢的效率顯著下降.應攷慮對不同人群採取不同的檢測程序.
목적 평개중국HIV항체검측책략재불동인군응용적효과화수익.방법 (1)수집103 133빈일반인군(림상취진병례、헌혈원、신병)표본、1276빈HIV감염고위인군(흡독인군、HIV감염자적배우)표본、2323빈생화화면역지표이상적표본,용현행HIV항체검측책략진행검측.(2)대2002-2008년무경총의원90 289인차림상병례HIV항체검측수거진행회고성분석;대3개성급학인중심실험실과거3~5년학인검측적결과진행회고성분석.결과 (1)사사시험적수익재고위인군여일반인군현저불동,고위인군사사양성자중HIV항체진양성적비례약위50%,현저고우일반인군;주요침대일반인군적학인실험실사사양성표본중진양성적비례위19.58%,현저저우주요침대고위인군적학인실험실.(2)2002-2008년림상HIV항체검측,수차사사양성적진양성솔유3.7%상승도16.0%,동시,복검효솔유92.6%하강위61.5%.(3)상견적생화화면역이상미증가HIV항체검측적비특이반응.결론 HIV항체사사양성예시HIV감염적의의재불동인군유현저차별,고위인군현저고우일반인군.수착근년래HIV항체검측시제질량적개진화실험실질량공제수평적제고,HIV항체수차사사적준학성대폭도제고,이복검적효솔현저하강.응고필대불동인군채취불동적검측정서.
Objective To evaluate the yield of HIV antibody testing strategy currently used on different populations, in China. Methods (1) The following samples were collected and tested according to the currently used HIV antibody testing strategy in China. 103 133 samples from the general populations (outpatients, new recruits and blood donors), 1276 people under high risk (spouses of the HIV infected individuals, intravenous drug users) and 2323 biochemical or immunological abnormal samples. (2) Retrospective analysis was done on data from the HIV testing among outpatients in General Hospital of People's Armed Police Forces, from Jan., 2002 to Dec.,2008 and in three provincial central HIV test and confirmatory laboratories. Results (1) The yields of HIV antibody screening were significantly different in different populations. The probability of screening reactive to be true positive was 50% in high risk population, significantly higher than in the general population. The probability of screening reactive to be true positive was 19.58% in the confirmatory laboratory mainly towards the general population, but significantly lower than results from the confirmatory laboratories done on the high risk population. (2) From 2002 to 2008, in the General Hospital of People's Armed Police Forces, the probability of screening reactive to be true positive in the clinical HIV test was increasing from 3.7% to 16.0%, where as the efficiency of the repeat screening testing decreased from 92.6% to 61.5%. Conclusion The predictive value of HIV antibody screening reactive was significantly greater in high risk population than in general population. The precision of HIV antibody initial screening was substantially increased with the improvement of HIV antibody test kits and of quality control in the HIV test laboratories in recent years. It is suggested that different HIV test strategies to be implemented in different populations.